Cell-free donor-derived DNA – an outstanding tool for early detection of graft injury after kidney transplantation
Written by Dan Hauzenberg
We are attending the GfH2023 conference in Kassel, Germany. The conference promises to offer a comprehensive overview of the field from leading experts and an opportunity to engage in scientific and clinical discussions with colleagues. Come and say hi to us at booth #39.
This whitepaper is authored by Stewart Payne, Consultant Clinical Scientist at UK National Health Service and Head of Molecular Genetics in the North West Thames Regional Genetics since 1995. Stewart’s laboratory was one of few in the UK offering CFTR whole gene analysis by Sanger sequencing and has recently translated whole gene analysis to next generation sequencing.
When planning to adopt a new NGS test in the clinical laboratory, many questions and practical considerations arise. Will introducing this new test increase or decrease complexity in the lab? Which activities will be impacted in the wet-lab and how will this affect cost-efficiency? What equipment, materials and reagents do I need to get started? How much training will be needed?
What you’ll learn
This guide addresses frequently asked questions and highlights key factors to consider when adding a new NGS test to your offering. Learn how recent advances in NGS protocols can simplify testing workflows in your lab - saving time, improving the quality of results, and increasing efficiency. You will also find links to useful resources, such as our sequence coverage calculators and NGS checklist tool.
Event | January 25-26, 2023
We are attending the Festival of Genomics & Biodata!
We are attending the annual get-together for the entire genomics and biodata community at Business Design Center in London. Make sure to stop by our booth #64 or simply just book a personal meeting with us!Book a meeting
Podcast | December 6, 2022Collaborations and homebrew assays by Dan Hauzenberger & Turid Sundin Carlsson
News | November 10, 2022Devyser Diagnostics AB publishes Interim Report for the period, January to September 2022
News | November 9, 2022Devyser strengthens its presence on the US market - establishes proprietary CLIA lab
Written by Dan Hauzenberg
Swedish molecular diagnostics company Devyser, announced today at the 45th annual European Bone...
Chimerism monitoring after hematopoietic stem cell transplantation (HSCT) plays a key role in...
Devyser offers an online Sequence Coverage Calculator to help plan your NGS run for optimal...